Eiger Mountains
Form DEF 14A
EIGER BIOPHARMACEUTICALS, INC. filed this Form DEF 14A on 04/26/2019
Document Outline
Entire Document (571 KB)
Subdocument 1 - DEF 14A - DEFINITIVE PROXY MATERIALS
Page 1 - SCHEDULE 14A INFORMATION
Page 2 - NOTICE OF ANNUAL MEETING OF STOCKHOLDERS
Page 3 - PROXY STATEMENT
Page 4 - What am I voting on?
Page 5 - How many votes do I have?
Page 6 - When are stockholder proposals and director nominations due for next year s annual meeting?
Page 7 - How many votes are needed to approve each proposal?
Page 8 - What proxy materials are available on the internet?
Page 9 - PROPOSAL 1
Page 10 - THE BOARD OF DIRECTORS RECOMMENDS
Page 11 - CLASS II DIRECTORS
Page 12 - CLASS III DIRECTORS
Page 13 - ROLE OF THE BOARD IN RISK OVERSIGHT
Page 14 - Audit Committee
Page 15 - Report of the Audit Committee of the Board of Directors
Page 16 - N/A
Page 17 - Compensation Committee Interlocks and Insider Participation
Page 18 - STOCKHOLDER COMMUNICATIONS WITH THE BOARD OF DIRECTORS
Page 19 - N/A
Page 20 - PROPOSAL 2
Page 21 - PRE-APPROVAL POLICIES AND PROCEDURES
Page 22 - EXECUTIVE OFFICERS
Page 23 - SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
Page 24 - N/A
Page 25 - SECTION 16(A) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE
Page 26 - EXECUTIVE COMPENSATION
Page 27 - Outstanding Equity Awards at Fiscal Year-End
Page 28 - Option Repricings
Page 29 - Nonqualified Deferred Compensation
Page 30 - N/A
Page 31 - TRANSACTIONS WITH RELATED PERSONS
Page 32 - HOUSEHOLDING OF PROXY MATERIALS
Page 33 - OTHER MATTERS
Page 34 - N/A
Page 35 - N/A